HUMAN HEMI-MYELOPEROXIDASE - INITIAL CHLORINATING ACTIVITY AT NEUTRAL PH, COMPOUND-II AND COMPOUND-III FORMATION, AND STABILITY TOWARDS HYPOCHLOROUS ACID AND HIGH-TEMPERATURE

被引:4
作者
ZUURBIER, KWM [1 ]
VANDENBERG, JD [1 ]
VANGELDER, BF [1 ]
MUIJSERS, AO [1 ]
机构
[1] UNIV AMSTERDAM,EC SLATER INST BIOCHEM RES,MEIBERGDREEF 15,1105 AZ AMSTERDAM,NETHERLANDS
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1992年 / 205卷 / 02期
关键词
D O I
10.1111/j.1432-1033.1992.tb16837.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human neutrophilic myeloperoxidase (MPO) is involved in the defence mechanism of the body against micro-organisms. The enzyme catalyses the generation of the strong oxidant hypochlorous acid (HOCl) from hydrogen peroxide and chloride ions. In normal neutrophils MPO is present in the dimeric form (140 kDa). The disulphide-linked protomers each consist of a heavy subunit and a light one. Reductive alkylation converts the dimeric enzyme into two protomers, 'hemi-myeloperoxidase'. We studied the initial activities of human dimeric MPO and hemi-MPO at the physiological pH of 7.2 and found no significant differences in chlorinating activity. These results indicate that, at least at neutral pH, the protomers of MPO function independently. The absorption spectra of MPO compounds II and III, both inactive forms concerning HOCl generation, and the rate constants of their formation were the same for dimeric MPO and hemi-MPO, but hemi-MPO required a slightly larger excess of H2O2 for complete conversion. Hemi-MPO was less stable at a high temperature (80-degrees-C) as compared to the dimeric enzyme. Furthermore, the resistance of the chlorinating activity of hemi-MPO against its oxidative product hypochlorous acid was somewhat lower (IC50 = 32-mu-M HOCl) compared to dimeric MPO (IC50 = 50-mu-M HOCl). The higher stability of dimeric MPO in the presence of its oxidative product compared to that of monomeric MPO might be the reason for the occurrence of MPO as a dimer.
引用
收藏
页码:737 / 742
页数:6
相关论文
共 47 条
[1]  
Agner K., 1972, STRUCTURE FUNCTION O, P329
[2]  
AGNER K, 1958, ACTA CHEM SCAND, V12, P95
[3]   INTACT FORM OF MYELOPEROXIDASE FROM NORMAL HUMAN-NEUTROPHILS [J].
ANDERSEN, MR ;
ATKIN, CL ;
EYRE, HJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1982, 214 (01) :273-283
[4]   QUANTITATIVE-DETERMINATION OF MYELOPEROXIDASE USING TETRAMETHYLBENZIDINE AS SUBSTRATE [J].
ANDREWS, PC ;
KRINSKY, NI .
ANALYTICAL BIOCHEMISTRY, 1982, 127 (02) :346-350
[5]  
ANDREWS PC, 1981, J BIOL CHEM, V256, P4211
[6]   COMPARISON OF MYELOPEROXIDASE AND HEMI-MYELOPEROXIDASE WITH RESPECT TO CATALYSIS, REGULATION, AND BACTERICIDAL ACTIVITY [J].
ANDREWS, PC ;
PARNES, C ;
KRINSKY, NI .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1984, 228 (02) :439-442
[7]   RAMAN CHARACTERIZATION OF HUMAN-LEUKOCYTE MYELOPEROXIDASE AND BOVINE SPLEEN GREEN HEMOPROTEIN - INSIGHT INTO CHROMOPHORE STRUCTURE AND EVIDENCE THAT THE CHROMOPHORES OF MYELOPEROXIDASE ARE EQUIVALENT [J].
BABCOCK, GT ;
INGLE, RT ;
OERTLING, WA ;
DAVIS, JC ;
AVERILL, BA ;
HULSE, CL ;
STUFKENS, DJ ;
BOLSCHER, BGJM ;
WEVER, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 828 (01) :58-66
[8]   BIOLOGICAL DEFENSE MECHANISMS - PRODUCTION BY LEUKOCYTES OF SUPEROXIDE A POTENTIAL BACTERICIDAL AGENT [J].
BABIOR, BM ;
KIPNES, RS ;
CURNUTTE, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (03) :741-744
[9]   ISOLATION PROCEDURE AND SOME PROPERTIES OF MYELOPEROXIDASE FROM HUMAN LEUKOCYTES [J].
BAKKENIST, ARJ ;
WEVER, R ;
VULSMA, T ;
PLAT, H ;
VANGELDER, BF .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 524 (01) :45-54
[10]  
BAKKENIST ARJ, 1981, THESIS U AMSTERDAM